News

Eledon Pharmaceuticals Rings the Closing Bell
About This EventEledon Pharmaceuticals (Nasdaq: ELDN), a clinical stage biotechnology company that is developing immune-modulating therapies for the management and treatment of life-threatening ...
Palantir Was the Top-Performing Stock in the S&P 500 and Nasdaq-100 During the First Half of 2025. Here Is What History Says Will Happen Next.
One stock that managed to outmaneuver the various headwinds torturing the markets throughout the year, however, is data ...
Best Stock to Buy Right Now: Uber vs. Tesla
Uber's stock has been on a tear in 2025. Shares are up over 55% through July 3. Even so, as the chart shows, Uber's P/E ratio ...